Men who eat at least two servings a week of yogurt may be lowering their risk for colorectal cancer, a recent study suggests.
Researchers examined data on 32,606 male and 55,743 female health professionals who had a colonoscopy between 1986 and 2012. Study participants provided detailed information about their health, lifestyle, eating and exercise habits every four years.
Over that time, there were 5,811 cases of colorectal adenomas in men and 8,116 in women.
Compared to men who didn’t eat any yogurt, those who had at least two servings weekly were 19% less likely to develop conventional adenomas and 26% less likely to develop adenomas with the highest malignant potential.
“Our data provide novel evidence for the role of yogurt in the early stage of colorectal cancer development,” said study coauthor Dr. Yin Cao of Washington University School of Medicine in St. Louis.
“The findings, if confirmed by future studies, suggest that yogurt might serve as a widely acceptable modifiable factor, which could complement colorectal cancer screening and reduce risk of adenoma among the unscreened,” Cao said by email.
Yogurt consumption has been linked to a lower risk of colon and rectal cancer in previous studies, and some scientists think this may be because yogurt promotes the growth of healthy bacteria in the gut. But less is known about how yogurt might impact the potential for people to develop adenomas.
In the study, yogurt consumption didn’t appear to impact the risk of pre-cancerous polyps in women.
“However, because this study took into account calcium intake, among other dietary factors, these results suggest that yogurt may be lowering risk though an avenue other than calcium,” Colditz said by email.
The probiotics in yogurt may be helping.
“Though it’s not clear that probiotics help lower colon cancer risk, there are a number of possible ways they could,” Colditz said. “Probiotics may help reduce inflammation – a cancer risk factor – as well as bind and neutralize certain carcinogens in the colon.”
[Disclaimer]The Site is operated by GDMeds and all rights thereto are owned and reserved by GDMeds. The contents and works on these pages compiled by GDMeds are subject to copyright law. Copying, processing, distribution and any kind of use outside the limits of copyright law require the written consent of GDMeds In case the content is not created by GDMeds the copyrights of third parties are being observed. However, if a user becomes aware of a copyright infringement, GDMeds asks the user for notification. Upon notification of such violations, GDMeds will remove the content immediately.
[免责声明]本网站由印度极得美运营。印度极得美拥有和保留一切权利。印度极得美的网页内容及文档受版权法保护。复制、加工、传播及任何超出版权法限制的任何使用行为均必须得到印度极得美书面许可。如相关内容如非由印度极得美创作，需遵守第三方的版权，特别是标示为第三方内容的。如用户发现侵犯版权的行为，请通知极得美。一旦收到违反通知，极得美将立刻移除相关内容。
[отказ]Сайт управляется GDMeds, и все права на него принадлежат и зарезервированы GDMeds. Содержание и работы на этих страницах, составленные GDMeds, защищены законом об авторском праве. Копирование, обработка, распространение и любое использование вне пределов авторского права требуют письменного согласия GDMeds. Если контент не создан GDMeds, то соблюдаются авторские права третьих лиц. Однако, если пользователь узнает о нарушении авторских прав, GDMeds запрашивает у пользователя уведомление. После уведомления о таких нарушениях GDMeds немедленно удалит контент.